Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

2-iminobiotin - Neurophyxia

Next Previous
X
Search
Drug Profile

2-iminobiotin - Neurophyxia

Alternative Names: 2-IB; 2-Iminobiotin; Neufix

Latest Information Update: 02 Oct 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Neurophyxia
  • Developer Neurophyxia; University Medical Center Utrecht
  • Class Imidazoles; Neuroprotectants; Pentanoic acids; Small molecules
  • Mechanism of Action Nitric oxide synthase type I inhibitors; Nitric oxide synthase type II inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Asphyxia
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Asphyxia

Most Recent Events

  • 03 Feb 2020 Phase II development is still ongoing for 2-iminobiotin for Asphyxia (Neurophyxia pipeline, February 2020)
  • 28 Sep 2017 University Medical Centre Utrecht and Neurophyxia completes a phase II trial in Asphyxia (In infants) in Netherlands (IV), before September 2017 (EudraCT2014-004265-25)
  • 23 May 2017 Neurophyxia terminates a phase II trial in Asphyxia (In neonates) because recruitment too slow and site decided to use hypothermia (exclusion criteria) in Turkey and Lithuania (IV) (NCT01626924)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top